References
Baltimore, D., F. Baylis, P. Berg, G.Q. Daley, J.A. Doudna, E.S. Lander, R. Lovell-Badge, P. Ossorio, D. Pei, A. Thrasher, et al. 2016. On human gene editing: International Summit Statement by the Organizing Committee. Issues in Science and Technology 32: 55–56.
Baltimore, D., Charo, A., Daley, G.Q., Doudna, J.A., Kato, K., Kim, J.-S., Lovell-Badge, R., Merchant, J., Nath, I., Pei, D., et al. 2018. On human genome editing II: Statement by the Organizing Committee of the Second International Summit on Human Genome Editing (Washington, DC: National Academy of Sciences).
Berg, P. 2008. Meetings that changed the world: Asilomar 1975: DNA modification secured. Nature 455: 290–291.
Dzau, V.J., M. McNutt, and C. Bai. 2018. Wake-up call from Hong Kong. Science 362: 1215.
Kinch, M.S. 2015. An overview of FDA-approved biologics medicines. Drug Discovery Today 20: 393–398.
Lander, E.S., F. Baylis, F. Zhang, E. Charpentier, P. Berg, C. Bourgain, B. Friedrich, J.K. Joung, J. Li, D. Liu, et al. 2019. Adopt a moratorium on heritable genome editing. Nature 567: 165–168.
Russo, E. 2003. Special Report: The birth of biotechnology. Nature 421: 456–457.
World Health Organization. 2004. Laboratory biosafety manual, 3rd ed. Geneva: World Health Organization.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Sun, B.Z. Review of Altered inheritance: CRISPR and the ethics of human genome editing by Françoise Baylis. Monash Bioeth. Rev. 38, 91–93 (2020). https://doi.org/10.1007/s40592-020-00106-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40592-020-00106-0